Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nir London

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Chemmedchem|February 22, 2022
Expanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted ScaffoldsArathy Jose, Daniel Guest, Remi LeGay, et al.
Cell|August 13, 2021
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapyKazuhiro Koikawa, Shin Kibe, Futoshi Suizu, et al.
Nature Chemical Biology|June 3, 2020
Identification of a potent and selective covalent Pin1 inhibitorBenika J Pinch, Zainab M Doctor, Behnam Nabet, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Nature Communications|January 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridgeChristopher F Bassil, Kerry Dillon, Gray R Anderson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Nature Chemical Biology|May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoChristian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Nature Chemical Biology|December 24, 2024
Thoughts for the futureLona M Alkhalaf, Cheryl Arrowsmith, Emily P Balskus, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Chemmedchem|February 22, 2022
Expanding the Repertoire of Low-Molecular-Weight Pentafluorosulfanyl-Substituted ScaffoldsArathy Jose, Daniel Guest, Remi LeGay, et al.
Cell|August 13, 2021
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapyKazuhiro Koikawa, Shin Kibe, Futoshi Suizu, et al.
Nature Chemical Biology|June 3, 2020
Identification of a potent and selective covalent Pin1 inhibitorBenika J Pinch, Zainab M Doctor, Behnam Nabet, et al.
Journal of the American Chemical Society|May 8, 2019
Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningEfrat Resnick, Anthony Bradley, Jinrui Gan, et al.
Nature Communications|January 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridgeChristopher F Bassil, Kerry Dillon, Gray R Anderson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of orally bioavailable Zika and West Nile Virus antiviral compounds targeting the NS2B-NS3 proteaseNathaniel T Kenton, Haim Barr, Artem Cherepakha, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Open-science discovery of DNDI-6510, a compound that addresses genotoxic and metabolic liabilities of the COVID Moonshot SARS-CoV-2 Mpro lead inhibitorEd J Griffen, Daren Fearon, Briana L McGovern, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Nature Chemical Biology|May 11, 2021
Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivoChristian Dubiella, Benika J Pinch, Kazuhiro Koikawa, et al.
Nature Chemical Biology|December 24, 2024
Thoughts for the futureLona M Alkhalaf, Cheryl Arrowsmith, Emily P Balskus, et al.
Pageof 9